Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

NCT00768664

Conditions
Disease Attributes, Head and Neck Neoplasms, Neoplasms, +4 more
Locations
  • BC Cancer Agency, Vancouver Centre Vancouver, British Columbia, Canada
  • Fairmont Medical Building Vancouver, British Columbia, Canada
  • Hamilton Health Sciences Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Completed

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03477643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Hospital de Sant Joan de Déu Barcelona, Spain
  • Hospital Donostia-Donostia Ospitalea Donostia / San Sebastian, Spain
  • Hospital Universitario Virgen de Las Nieves Granada, Spain
  • Hospital General San Jorge - Huesca Huesca, Spain
View all 27 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT01445080

Conditions
Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

NCT01380106

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Central Arkansas Veterans Healthcare System Little Rock, Arkansas, United States
  • West Los Angeles VA Medical Center Los Angeles, California, United States
  • Edward Hines Jr VA Hospital Hines, Illinois, United States
  • VA Boston Healthcare System Jamaica Plain, Massachusetts, United States
View Trial Details

Related conditions